Literature DB >> 12754158

Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia.

Vicente Molina1, Santiago Reig, Manuel Desco, Juan D. Gispert, Javier Sanz, Fernando Sarramea, Javier Pascau, Carlos Benito, Raul Martínez-Lázaro, Rogelio Luque, María Aragües, Jose M. Misiego, Ignacio López Corral, Thomás Palomo.   

Abstract

The interpretation of the huge number of results in schizophrenia research using neuroimaging is uncertain. However, the simultaneous use of complimentary data obtained with these techniques may yield more relevant information in this regard. In this paper we present a series of studies performed by our group in two schizophrenic samples with the use of structural (magnetic resonance imaging, MRI), functional [glucose positron emission tomography (PET) and N-acetyl-aspartate (NAA) magnetic resonance spectrocopy] and neurophysiological techniques (the P300 event-related potential). Transversal and longitudinal measurements were performed.The integrated vision of the results so obtained allows us to propose the hypothesis of a neurodevelopmentally determined state of prefrontal disinihibition, in which the degree of atrophy would directly relate to the metabolic rate. This state would already be present in the first stages of illness and could have neurotoxic consequences in the long term. This would explain the findings of an association between sulcal cerebrospinal fluid (CSF) and illness duration and decreased NAA levels in chronic but not in recent-onset cases. The prefrotnal disinhibition would overstimulate the limbic system and the hippocampus would become overactivated, the metabolic rate at this level being inversely related to P300 amplitude. Clozapine showed a more selective and intense action on that hyperactive metabolic tone than haloperidol.

Entities:  

Year:  2002        PMID: 12754158     DOI: 10.1080/10298420290031397

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  90 in total

Review 1.  Stereological quantitation of human brains from normal and schizophrenic individuals.

Authors:  B Pakkenberg
Journal:  Acta Neurol Scand Suppl       Date:  1992

Review 2.  Architecture and cortical connections of the prefrontal cortex in the rhesus monkey.

Authors:  H Barbas
Journal:  Adv Neurol       Date:  1992

3.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins.

Authors:  D R Weinberger; K F Berman; R Suddath; E F Torrey
Journal:  Am J Psychiatry       Date:  1992-07       Impact factor: 18.112

4.  Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.

Authors:  T D Cannon; T G van Erp; M Huttunen; J Lönnqvist; O Salonen; L Valanne; V P Poutanen; C G Standertskjöld-Nordenstam; R E Gur; M Yan
Journal:  Arch Gen Psychiatry       Date:  1998-12

5.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

Authors:  B Moghaddam; B W Adams
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

6.  NMDA-dependent modulation of CA1 local circuit inhibition.

Authors:  H C Grunze; D G Rainnie; M E Hasselmo; E Barkai; E F Hearn; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

7.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

8.  Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat.

Authors:  A C Grobin; A Y Deutch
Journal:  J Pharmacol Exp Ther       Date:  1998-04       Impact factor: 4.030

9.  Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs.

Authors:  L W Fitzgerald; A Y Deutch; G Gasic; S F Heinemann; E J Nestler
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

10.  Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia.

Authors:  A Pfefferbaum; R B Zipursky; K O Lim; L M Zatz; S M Stahl; T L Jernigan
Journal:  Arch Gen Psychiatry       Date:  1988-07
View more
  2 in total

1.  Neurodevelopmental liabilities in schizophrenia and affective disorders.

Authors:  Tomás Palomo; Richard M. Kostrzewa; Trevor Archer; Richard J. Beninger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 2.  Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.